1. Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy
2. Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany
3. Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany
4. Novartis Pharma AG, Basel, Switzerland
5. Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain